CLYM: Climb Bio, Inc. Stock

by  •  • Comments Off on CLYM: Climb Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 214.78
Enterprise Value ($M) 68.60
Book Value ($M) 218.78
Book Value / Share 3.25
Price / Book 0.98
NCAV ($M) 194.19
NCAV / Share 2.89
Price / NCAV 1.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 57.73
Current Ratio 57.73

Balance Sheet (mrq) ($M)
Current Assets 197.61
Assets 222.20
Liabilities 3.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Deep Track Capital, LP 3.23 -44.45
4 days ago 13D/A Access Industries Management, Llc 7.25
08-16 13D/A Ai Eti Llc 7.50 0.00
08-14 13G/A Affinity Asset Advisors, LLC 2.70 8.57
07-01 13D/A Ra Capital Management, L.p. 47.10 138.49
02-07 13G/A BML Investment Partners, L.P. 8.50 23.88

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 44,099 402,598 10.95
2024-11-14 78,663 402,060 19.56
2024-11-13 35,600 161,624 22.03
2024-11-12 47,594 199,602 23.84
2024-11-11 52,594 278,870 18.86

(click for more detail)

Similar Companies
CGTX – Cognition Therapeutics, Inc. CHRS – Coherus BioSciences, Inc.
CLSD – Clearside Biomedical, Inc. CMRX – Chimerix, Inc.
CRMD – CorMedix Inc.


Financial data and stock pages provided by
Fintel.io